
Clinical Chemistry, Immunology and Laboratory Quality Control
A Comprehensive Review for Board Preparation, Certification and Clinical Practice
- 2nd Edition - May 4, 2021
- Imprint: Elsevier
- Authors: Amitava Dasgupta, Amer Wahed
- Language: English
- Paperback ISBN:9 7 8 - 0 - 1 2 - 8 1 5 9 6 0 - 6
- eBook ISBN:9 7 8 - 0 - 1 2 - 8 1 5 9 6 1 - 3
Clinical Chemistry, Immunology and Laboratory Quality Control: A Comprehensive Review for Board Preparation, Certification and Clinical Practice, Second Edition presents core topi… Read more

Purchase options

Institutional subscription on ScienceDirect
Request a sales quoteClinical Chemistry, Immunology and Laboratory Quality Control: A Comprehensive Review for Board Preparation, Certification and Clinical Practice, Second Edition presents core topics and 70 case studies that illustrate the application of clinical chemistry knowledge to everyday patient care. This succinct reference offers practical examples of how things function in the pathology clinic with useful lists, key points, case studies and a bullet point format ideal for quick pre-board review. While larger textbooks in clinical chemistry provide highly detailed information regarding instrumentation and statistics, this book is designed to educate senior medical students, residents and fellows on how tests are performed.
This second edition successfully helps pathology residents gain command of clinical chemistry, toxicology, immunology, and laboratory statistics in an effort to help them prepare for the American Board of Pathology examination. Clinical chemistry is a topic in which many senior medical students and pathology residents face challenges.
- Includes chapters on drug-herb interaction and pharmacogenomics, topics not covered by textbooks in the field of clinical chemistry or laboratory medicine
- Presents seventy case studies that highlight clinical relevance and errors to avoid
- Covers important clinical information found in larger textbooks in a more succinct and easy-to-understand manner
- Cover image
- Title page
- Table of Contents
- Copyright
- Preface
- Chapter 1: Instrumentation and analytical methods
- Abstract
- Instrumentation and analytical methods: An introduction
- Spectrophotometry and related techniques
- Atomic absorption
- Enzymatic assays
- Immunoassays
- Turbidimetry and nephelometry: Methods based on light scattering
- Ion selective electrodes
- Basic principles of chromatography
- Gas chromatography
- High-performance liquid chromatography
- Mass spectrometer as a detector
- Examples of application of chromatographic techniques in clinical toxicology laboratories
- Automation in clinical laboratory
- Electrophoresis including capillary electrophoresis
- Summary/key points
- Chapter 2: Immunoassay design and issues of interferences
- Abstract
- Application of immunoassays for various analytes
- Immunoassay design and principle
- Various commercially available immunoassays
- Heterogenous immunoassays
- Calibration of an immunoassay
- Various sources of interferences in immunoassays
- Interferences from bilirubin, hemolysis, and high lipid content
- Interferences from the endogenous and exogenous components
- Interferences of heterophilic antibodies in immunoassays
- Rheumatoid factor interferences
- Interferences from autoantibodies
- Macroenzyme interferences
- Other macroanalytes
- Prozone (or “hook”) effect
- Summary/key points
- Chapter 3: Preanalytical variables
- Abstract
- Laboratory errors
- Order of draw of blood collection tubes
- Errors in patient preparation
- Biological rhythm and time for specimen collection
- Errors with patient identification and related errors
- Error of collecting blood in wrong tubes: Effect of anticoagulants
- Blood collection from catheter and intravenous line
- Issues with collecting urine specimens
- Issues with specimen processing and transportation
- Special issues: Blood gas and ionized calcium analysis
- Summary/key points
- Chapter 4: Laboratory statistics and quality control
- Abstract
- Mean, standard deviation, and coefficient of variation
- Precision and accuracy
- Gaussian distribution and reference range
- Sensitivity, specificity, and predictive value
- Random and systematic errors in measurements
- Laboratory quality control: Internal and external
- CAP proficiency testing
- Passing CAP proficiency testing
- What action to take if a laboratory failed CAP survey for certain analytes?
- Levey-Jennings chart and Westgard rules
- Delta checks
- Method validation for a new test using existing analyzer
- How to interpret regression equation?
- Bland-Altman plot
- How to implement a new analyzer in the laboratory?
- Analytical measurement range, reference range, and critical values
- Quality assurance indicators in the laboratory
- Receiver operating characteristic curve
- What is six sigma?
- Errors associated with reference range
- Basic statistical analysis: Student’s t-test and related tests
- Summary/key points
- Chapter 5: Water homeostasis electrolytes and acid-base balance
- Abstract
- Distribution of water and electrolytes in human body
- Plasma and urine osmolality
- Hormones involved in water and electrolyte balance
- Renin-angiotensin-aldosterone system
- Diabetes insipidus
- The syndrome of inappropriate antidiuretic hormone secretion (SIADH)
- Hyponatremia, sick cell syndrome, and hypernatremia
- Hypokalemia and hyperkalemia
- Introduction to acid-base balance
- Diagnostic approach to acid-base disturbance
- Short cases: Acid-base disturbances
- Key points
- Chapter 6: Lipid metabolism and disorders
- Abstract
- Lipids and lipoproteins
- Various classes of lipoproteins
- Lipid metabolism
- LDL metabolism
- HDL metabolism
- Lipid profile and risk of cardiovascular disease
- Various types of hyperlipidemia
- Various types of hypolipidemia
- Newer lipid parameters and other factors related to risk for cardiovascular disease
- Laboratory measurements of various lipids
- Drugs for treating lipid disorders
- Summary/key points
- Chapter 7: Carbohydrate metabolism, diabetes, and hypoglycemia
- Abstract
- Carbohydrates: An introduction
- Regulation of blood glucose concentration
- Diabetes mellitus: Basic concepts
- Monogenic diabetes mellitus
- Type 1 diabetes mellitus
- Metabolic syndrome or syndrome X
- Complications of diabetes
- Secondary causes of diabetes mellitus
- Diagnostic criteria for diabetes
- Hypoglycemia
- Laboratory methods
- Glucose meters
- Summary/key points
- Chapter 8: Cardiac markers
- Abstract
- Myocardial infarction
- Overview of cardiac markers
- Myoglobin
- CK isoenzyme: CK-MB
- Troponin I and troponin T
- High-sensitivity troponin assays
- Elevated troponin levels in conditions other than myocardial infarction
- Issues of interferences
- LDH: An old cardiac marker
- Biomarkers of myocardial ischemia
- Biomarkers of hemodynamic stress of the heart
- Inflammatory and prognostic biomarkers
- Pregnancy-associated plasma protein A
- Summary/key points
- Chapter 9: Endocrinology
- Abstract
- Introduction to various endocrine glands
- Hypothalamus
- Pituitary gland
- Thyroid gland
- Thyroid function tests
- Hypothyroidism
- Hyperthyroidism
- Disorders of parathyroid glands
- Adrenal glands
- Cushing’s syndrome
- Conn’s syndrome
- Hypoadrenalism including Addison’s disease
- Dysfunctions of gonads
- Pancreatic endocrine disorders
- Multiple endocrine neoplasia
- Endocrine testing: Suppression and stimulation tests
- Summary/key points
- Chapter 10: Liver diseases and liver function tests
- Abstract
- Liver physiology
- Liver function tests and interpretations
- Jaundice: An introduction
- Congenital hyperbilirubinemia
- Hemolytic (prehepatic) jaundice
- Hepatocellular jaundice
- Chronic liver disease
- Cholestatic jaundice
- Alcohol and drug-induced liver disease
- Liver disease in pregnancy
- Liver disease in neonates and children
- Nonalcoholic fatty liver disease
- Macro liver enzymes
- Delta bilirubin
- Laboratory measurement of bilirubin and other tests
- Summary/key points
- Chapter 11: Renal function tests
- Abstract
- Basic functions of kidneys
- Glomerular filtration rate
- Creatinine clearances and estimated GFR
- Biochemical assessment of renal function
- Assessment of glomerular integrity
- Tests for renal tubular function
- Acute renal failure
- BUN/creatinine ratio
- Fractional excretion of sodium
- Chronic kidney disease
- Proteinuria
- Nephrotic syndrome
- Nephritic syndrome
- Hematuria
- Glomerular versus nonglomerular bleeding
- Fanconi syndrome
- Renal tubular acidosis
- Renal calculi
- Laboratory measurements of creatinine and related tests
- Urine dipstick analysis
- Summary/key points
- Chapter 12: Inborn errors of metabolism
- Abstract
- Overview of inborn errors of metabolism
- Amino acid disorders
- Carbohydrate metabolism disorders
- Urea cycle disorders
- Organic acid disorders (organic aciduria)
- Fatty acid oxidation disorders
- Mitochondrial disorders
- Peroxisomal disorders
- Lysosomal storage disorders
- Purine or pyrimidine metabolic disorders
- Disorders of porphyrin metabolism
- Newborn screening and evaluation
- Summary/key points
- Chapter 13: Tumor markers
- Abstract
- Introduction to tumor markers
- Clinical uses of tumor markers and common tumor markers
- Prostate-specific antigen (PSA)
- False-positive and unexpected PSA results
- Cancer antigen 125 (carbohydrate antigen 125: CA-125)
- False-positive CA-125
- Cancer antigen-19-9 (carbohydrate antigen: 19-9: CA 19-9)
- Alpha-fetal protein (AFP, α-fetoprotein)
- False-positive AFP
- Carcinoembryonic antigen (CEA)
- False-positive CEA
- β2-Microglobulin
- Human chorionic gonadotropin (hCG)
- Causes and evaluation of persistent low level of hCG
- False-positive hCG
- CA-15-3 and HER2
- CA 72-4
- Markers for thyroid cancer
- Less commonly monitored cancer biomarkers
- Summary/key points
- Chapter 14: Therapeutic drug monitoring
- Abstract
- What is therapeutic drug monitoring?
- Drugs that require therapeutic drug monitoring
- Free versus total drug monitoring
- Therapeutic drug monitoring benefits
- Basic pharmacokinetics
- Effect of gender and pregnancy on drug metabolism and disposition
- Effect of age on drug metabolism and disposition
- Drug metabolism and disposition in uremia
- Drug metabolism and disposition in liver disease
- Effect of cardiovascular disease on drug metabolism and disposition
- Thyroid dysfunction and drug metabolism
- Effect of food, alcohol consumption, and smoking on drug disposition
- Therapeutic drug monitoring of various drug classes: General considerations
- Preanalytical issues in therapeutic drug monitoring
- Therapeutic drug monitoring of anticonvulsants
- Therapeutic drug monitoring of cardioactive drugs
- Therapeutic drug monitoring of antiasthmatic drugs
- Therapeutic drug monitoring of antidepressants
- Therapeutic drug monitoring of immunosuppressants
- Therapeutic drug monitoring of selected antibiotics
- Therapeutic drug monitoring of antineoplastic drugs
- Therapeutic drug monitoring of antiretrovirals
- Therapeutic drug monitoring using oral fluids
- Therapeutic drug monitoring using dried blood spot
- Summary/key points
- Chapter 15: Interferences in therapeutic drug monitoring
- Abstract
- Methodologies used in therapeutic drug monitoring and issues of interferences
- Effect of endogenous factors on therapeutic drug monitoring
- Digoxin immunoassays: So much interference
- Interferences in analysis of antiepileptics
- Interferences in analysis of tricyclic antidepressants
- Interferences in analysis of immunosuppressants
- Interferences in analysis of antibiotics
- Interferences of paraprotein in therapeutic drug monitoring
- Summary/key points
- Chapter 16: Drugs of abuse testing
- Abstract
- Commonly abused drugs in the United States
- Medical versus workplace drug testing
- SAMHSA versus non-SAMHSA drugs
- Detection window of various drugs in urine
- Metabolism of abused drugs/target of immunoassay antibody
- Immunoassays versus confirmation
- False-positive immunoassay test results with various abused drugs
- False-negative test results
- Derivatization in GC/MS vs direct analysis using LC-MS/MS
- Analytical true positive due to use of prescription drugs and other factors
- Issues of adulterated urine specimens in workplace drug testing
- Miscellaneous other issues in drugs of abuse testing
- Summary/key points
- Chapter 17: Designer drugs, date rape drugs, LSD, volatiles, magic mushroom, and peyote cactus abuse
- Abstract
- Negative toxicology report
- Abuse of amphetamine-like designer drugs including bath salts
- Abuse of synthetic marijuana (Spice, K2)
- Designer drugs that are opioid analogs
- Meperidine and phencyclidine-like designer drugs
- Rave party drugs and date rape drugs
- LSD abuse
- Abuse of volatiles (solvents)
- Magic mushroom abuse
- Peyote cactus abuse
- Summary/key points
- Chapter 18: Testing for ethyl alcohol (alcohol) and other volatiles
- Abstract
- Alcohol use and abuse
- Health benefits of moderate drinking
- Health hazards of heavy drinking
- Metabolism of alcohol: Effect of gender
- Metabolism of ethyl alcohol: Effect of genetic factors
- Relation between whole blood alcohol and serum alcohol and legal limit of driving
- Analysis of alcohol in body fluids: Limitations and pitfalls
- Headspace gas chromatography for alcohol determination
- Breath alcohol measurement
- Biomarkers of alcohol abuse
- Methanol abuse
- Abuse of ethylene glycol and other alcohols
- Summary/key points
- Chapter 19: Common poisonings including heavy metal poisoning
- Abstract
- Poisoning from analgesics
- Methyl salicylate poisoning
- Carbon monoxide poisoning
- Cyanide poisoning
- Overdose with tricyclic antidepressants
- Benzodiazepine and opiate overdose
- Alcohol poisoning
- Poisoning from organophosphorus and carbamate insecticides
- Lead poisoning
- Mercury poisoning
- Arsenic poisoning
- Poisoning from other metals
- Summary/key points
- Chapter 20: Pharmacogenomics
- Abstract
- Introduction to pharmacogenomics
- Basic pharmacogenomics
- Nomenclature
- Various metabolizer types
- Other polymorphic enzymes that metabolize drugs
- Polymorphism of transporter proteins and receptors
- Pharmacogenomics and warfarin therapy
- Pharmacogenomics of selected anticancer drugs
- Pharmacogenomics of selected opioid drugs
- Pharmacogenomics of selected psychoactive drugs
- Pharmacogenomics of miscellaneous other drugs
- Methods for pharmacogenomics testing
- Summary/key points
- Chapter 21: Point-of-care testing
- Abstract
- Introduction to point-of-care testing
- POCT devices: Methodologies
- Glucose measurement using POCT
- Measuring multiple analytes using POCT
- Cardiac markers
- Pregnancy test
- Coagulation POCT
- Infectious disease
- POCT for drugs of abuse
- Important issues with POCT devices
- Key points
- Chapter 22: Biotin interferences with immunoassays
- Abstract
- Biotin
- Serum biotin levels
- Biotin interference
- FDA safety communication on biotin
- Biotin interferences in thyroid function tests
- Biotin falsely lower parathyroid hormone level
- Biotin interferes with cardiac function tests
- Biotin interferences in multiple immunoassays
- Diagnostic companies using biotin-based assays: A review
- Approaches to overcome biotin interference
- Key points
- Chapter 23: Hemoglobinopathies and thalassemia
- Abstract
- Introduction
- Hemoglobin structure and synthesis
- Introduction to hemoglobinopathies
- Alpha-thalassemia
- Beta-thalassemia
- Delta-thalassemia
- Sickle cell disease
- Hereditary persistence of fetal hemoglobin (HPFH)
- Other hemoglobin variants
- Laboratory investigation of hemoglobinopathies
- Gel electrophoresis
- Interpretation of alkaline and acid gels
- High-performance liquid chromatography (HPLC)
- Capillary electrophoresis
- Reporting normal hemoglobin pattern
- Diagnostics tips for thalassemia, sickle cell disease, and other hemoglobinopathies
- Apparent hemoglobinopathy after blood transfusion
- Universal newborn screening
- Key points
- Chapter 24: Protein electrophoresis and immunofixation
- Abstract
- Introduction
- Serum protein electrophoresis
- Urine electrophoresis
- Immunofixation studies
- Capillary zone electrophoresis
- Free light chain assay
- Mass spectrometry in diagnosis of multiple myeloma
- Paraprotein interferences in clinical laboratory tests
- Other plasma cell disorders
- Morphology of plasma cells in myeloma
- Cerebrospinal fluid electrophoresis
- Summary/key points
- Chapter 25: Human immunodeficiency virus (HIV) and hepatitis testing
- Abstract
- Human immunodeficiency virus testing
- Window period in HIV infection
- Standard HIV testing
- Testing algorithm
- Rapid HIV antibody testing
- Confirmatory HIV test
- HIV viral load test and related assays
- Introduction to hepatitis testing
- Testing for hepatitis B
- Testing for hepatitis C
- Immunization and false-positive HIV and hepatitis testing
- Testing for Epstein-Bar virus
- Summary/key points
- Chapter 26: Autoimmunity, complement, and immunodeficiency
- Abstract
- Introduction to immune system and complement
- T lymphocytes and cell-mediated immunity
- B cells and humoral immunity
- Pathways of complement activation
- Immunodeficiency
- Major histocompatibility complex
- HLA testing
- Transplant rejection
- Autoimmune serology
- Hypersensitivity reactions and hypersensitivity-mediated disorders
- Summary/key points
- Chapter 27: Effect of herbal supplements on clinical laboratory test results
- Abstract
- Use of herbal remedies in the United States
- How herbal remedies affect clinical laboratory test results
- Liver damage as reflected by abnormal liver function test after using certain herbals
- Kidney damage and herbal supplements
- Kelp and thyroid function
- Miscellaneous abnormal test results due to use of certain herbals
- Drug-herb interactions
- Herbs adulterated with western drugs and herbs contaminated with heavy metals
- Grapefruit juice-drug interaction
- Summary/key points
- Index
- Edition: 2
- Published: May 4, 2021
- No. of pages (Paperback): 600
- No. of pages (eBook): 600
- Imprint: Elsevier
- Language: English
- Paperback ISBN: 9780128159606
- eBook ISBN: 9780128159613
AD
Amitava Dasgupta
Amitava Dasgupta received his Ph. D in chemistry from Stanford University and completed his fellowship training in Clinical Chemistry from the Department of Laboratory Medicine at the University of Washington School of Medicine at Seattle. He is board certified in both Toxicology and Clinical Chemistry by the American Board of Clinical Chemistry. Currently, he is a tenured Full Professor of Pathology and Laboratory Medicine at the University of Kansas Medical Center and Director of Clinical Laboratories at the University of Kansas Hospital. Prior to this appointment he was a tenured Professor of Pathology and Laboratory Medicine at the University of Texas McGovern medical School from February 1998 to April 2022. He has 252 papers to his credit. He is in the editorial board of four journals including Therapeutic Drug Monitoring, Clinica Chimica Acta, Archives of Pathology and Laboratory Medicine, and Journal of Clinical Laboratory Analysis.
AW